Treatment for Gastroparesis
The management of gastroparesis should begin with dietary modifications, followed by metoclopramide as first-line pharmacological therapy, with alternative medications, gastric electrical stimulation, and nutritional support considered for refractory cases. 1
Dietary Management
- Recommend small, frequent meals (5-6 per day) that are low in fat and fiber
- Increase liquid calories and foods with small particle size
- Focus on complex carbohydrates and energy-dense liquids
- Advise patients to avoid:
- Carbonated beverages
- Alcohol
- Smoking
- Early dietitian involvement is strongly recommended, especially for severe cases 1
Pharmacological Management
First-Line Medications
- Metoclopramide: 10 mg orally, 30 minutes before meals and at bedtime
Alternative Prokinetics
- Erythromycin: 40-250 mg orally 3 times daily
- Effective alternative but limited by tachyphylaxis with long-term use 1
Antiemetics for Symptom Control
- Ondansetron: 4-8 mg 2-3 times daily
- Prochlorperazine: 5-10 mg 4 times daily
- Trimethobenzamide: 300 mg 3 times daily 1
Medications to Avoid
- Opioids
- Anticholinergics
- Tricyclic antidepressants
- GLP-1 receptor agonists
- Pramlintide 1
Management in Special Populations
Diabetic Gastroparesis
- Withdraw medications that adversely affect GI motility, including GLP-1 RAs
- Consider DPP-4 inhibitors for glucose control (neutral effect on gastric emptying)
- Insulin therapy remains an option with appropriate dose adjustments
- Metformin or SGLT-2 inhibitors may be considered if not contraindicated 1
Advanced Interventions for Refractory Cases
Nutritional Support (Stepwise Approach)
- Modified solid food diet
- Blended or pureed foods
- Liquid diet with oral nutritional supplements
- Enteral nutrition via jejunostomy tube
- Parenteral nutrition (last resort) 1, 3
Gastric Electrical Stimulation
- Consider for medication-refractory symptoms
- May relieve symptoms including weekly vomiting frequency
- Can reduce need for nutritional supplementation 1, 3
Surgical Options
- Gastric emptying procedures (e.g., pyloroplasty)
- Total gastrectomy in rare cases where all other treatments have failed 1
Monitoring and Follow-up
- Regular assessment of nutritional status
- Monitor for medication side effects, particularly with metoclopramide
- Electrolyte monitoring, especially with persistent vomiting 1
Common Pitfalls and Caveats
- Metoclopramide should be used with caution due to risk of tardive dyskinesia; limit to 12 weeks when possible
- Erythromycin effectiveness decreases over time due to tachyphylaxis
- Overly restrictive diets can worsen nutritional deficiencies
- Patients with renal impairment should receive approximately half the recommended metoclopramide dosage 1, 2
- Young female patients have higher prevalence of idiopathic gastroparesis and may have psychological factors contributing to symptoms 1